Overview A 36-Week Extension to Protocol ISA04-03 Status: Completed Trial end date: 2006-07-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine the safety and efficacy of voclosporin in patients with plaque psoriasis. Phase: Phase 3 Details Lead Sponsor: Aurinia Pharmaceuticals Inc.